1 – 10 of 18
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
- No breast cancer subgroup can be spared postoperative radiotherapy after breast-conserving surgery. Fifteen-year results from the Swedish Breast Cancer Group randomised trial, SweBCG 91 RT
- 2013
- Mammography casting-type calcification and risk of local recurrence in DCIS: analyses from a randomised study
- 2009
- Increased cardiovascular morbidity and mortality following endocrine treatment for prostate cancer: an analysis in 30,642 men in PCBaSe Sweden
- Cyclin B1 Is an Independent Prognostic Proliferation Marker with a High Reproducibility in a Population-Based Lymph Node Negative Breast Cancer Cohort
- 2008
- Self-selection in sigmoidoscopy screening: A nine-year follow-up study
- 2007
- Histopathological risk factors for ipsilateral breast events after breast conserving treatment for ductal carcinoma in situ of the breast - Results from the Swedish randomised trial.
- 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
- 2004
- HABITS (hormonal replacement therapy after breast cancer - is it safe?), a randomised comparison: trial stopped
- Stopping HABITS - Reply
- Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancer